* history of asthma, history of allergy to the vaccine or vaccine components,or serious adverse reactions to the vaccine, such as urticaria, dyspnea,and angioedema; * severe neurological disease (epilepsy, convulsions or convulsions) or mental illness; * fever at the time of vaccination, or acute onset of chronic disease, or uncontrolled severe chronic disease, or acute disease; * pregnancy or lactation; * receipt of attenuated live vaccines in the past 14 days; * receipt of inactivated or subunit vaccines in the past 7 days * according to the investigator's judgment, the subject has any other factors that are not suitable for participating in the clinical trial.

* history of asthma, history of allergy to the vaccine or vaccine components,or serious adverse reactions to the vaccine, such as urticaria, dyspnea,and angioedema; * severe neurological disease (epilepsy, convulsions or convulsions) or mental illness; * fever at the time of vaccination, or acute onset of chronic disease, or uncontrolled severe chronic disease, or acute disease; * pregnancy or lactation; * receipt of attenuated live vaccines in the past 14 days; * receipt of inactivated or subunit vaccines in the past 7 days * according to the investigator's judgment, the subject has any other factors that are not suitable for participating in the clinical trial.

history of asthma, history of allergy to the vaccine or vaccine components,or serious adverse reactions to the vaccine, such as urticaria, dyspnea,and angioedema; severe neurological disease (epilepsy, convulsions or convulsions) or mental illness; fever at the time of vaccination, or acute onset of chronic disease, or uncontrolled severe chronic disease, or acute disease; pregnancy or lactation; receipt of attenuated live vaccines in the past 14 days; receipt of inactivated or subunit vaccines in the past 7 days according to the investigator's judgment, the subject has any other factors that are not suitable for participating in the clinical trial.

history of asthma, history of allergy to the vaccine or vaccine components,or serious adverse reactions to the vaccine, such as urticaria, dyspnea,and angioedema; severe neurological disease (epilepsy, convulsions or convulsions) or mental illness; fever at the time of vaccination, or acute onset of chronic disease, or uncontrolled severe chronic disease, or acute disease; pregnancy or lactation; receipt of attenuated live vaccines in the past 14 days; receipt of inactivated or subunit vaccines in the past 7 days according to the investigator's judgment, the subject has any other factors that are not suitable for participating in the clinical trial.